September, 2025 - Rapha Capital Management, LLC

egalli In News, Portfolio, Press Releases, PrintBio, Inc., Rapha Capital Management

PrintBio Introduces DynaFlex™ Programmable Surgical Mesh (PSM) at American Hernia Society Meeting 2025

DynaFlex™ Incorporates MetaDirectional Flex™ Technology to Create the First-of-Its-Kind Programmable Mesh Our introduction of DynaFlex™ represents a new era in...

egalli In News, Portfolio, Press Releases, PrintBio, Inc., Rapha Capital Management

PrintBio Reorganizes and Expands Leadership Team with Key Commercial and Market Development Appointments

• Launches Hernia Division to Focus on Abdominal Wall Repair Solutions • Strengthens Leadership to Drive Market Readiness for Surgical...

egalli In Eos SENOLYTIX, News, Perseus SENOLYTIX, Phoenix SENOLYTIX, Portfolio, Press Releases, Rapha Capital Management, SENOTHERAPEUTIX

MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies

Agreement focuses on rimiducid, an agent used to activate certain “safety switch” cell elimination technologies in cell and gene therapies...

September 2025

PrintBio Introduces DynaFlex™ Programmable Surgical Mesh (PSM) at American Hernia Society Meeting 2025

PrintBio Reorganizes and Expands Leadership Team with Key Commercial and Market Development Appointments

MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies

Categories

Archives